CHIAPPALUPI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.045
AS - Asia 1.616
EU - Europa 1.462
SA - Sud America 333
AF - Africa 58
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.529
Nazione #
US - Stati Uniti d'America 1.970
SG - Singapore 736
IT - Italia 488
BR - Brasile 271
CN - Cina 222
IE - Irlanda 206
HK - Hong Kong 197
RU - Federazione Russa 156
DE - Germania 110
VN - Vietnam 97
FR - Francia 89
KR - Corea 89
SE - Svezia 60
GB - Regno Unito 55
FI - Finlandia 48
IN - India 48
NL - Olanda 48
RO - Romania 40
CA - Canada 38
AT - Austria 32
UA - Ucraina 32
JP - Giappone 26
PH - Filippine 26
TR - Turchia 26
BD - Bangladesh 25
IQ - Iraq 25
MX - Messico 22
ZA - Sudafrica 21
PL - Polonia 19
ES - Italia 18
BE - Belgio 15
CO - Colombia 15
PK - Pakistan 14
AR - Argentina 13
CH - Svizzera 10
EC - Ecuador 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
AU - Australia 8
ID - Indonesia 8
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
TN - Tunisia 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
MD - Moldavia 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
EG - Egitto 4
JO - Giordania 4
KH - Cambogia 4
LT - Lituania 4
MY - Malesia 4
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
CV - Capo Verde 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
IS - Islanda 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
Totale 5.526
Città #
Singapore 574
Chandler 253
San Jose 205
Dublin 202
Perugia 195
Hong Kong 187
Ashburn 147
San Mateo 89
Santa Clara 84
Boardman 77
Moscow 67
The Dalles 62
Beijing 52
Lauterbourg 51
Los Angeles 47
Dearborn 44
Redmond 44
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Princeton 40
Wilmington 38
Seoul 36
Bucharest 34
New York 31
Ho Chi Minh City 30
São Paulo 28
Vienna 28
Bologna 27
Andover 26
Lawrence 23
Falls Church 19
Seongnam-si 19
Tokyo 18
Orem 17
Hanoi 16
Montreal 16
Piscataway 16
Brussels 15
Amsterdam 14
Johannesburg 14
Cebu City 13
Falkenstein 13
Norwalk 12
Helsinki 11
Nuremberg 11
Phoenix 11
Warsaw 11
Brooklyn 10
Council Bluffs 10
London 10
Milan 10
Rome 10
Saint Petersburg 10
Turku 10
Baghdad 9
Boston 9
Denver 9
Parma 9
Redwood City 9
Atlanta 8
Brasília 8
Da Nang 8
Dallas 8
Frankfurt am Main 8
Groningen 8
Houston 8
Istanbul 8
Jacksonville 8
Mumbai 8
Tijuana 8
Chennai 7
Columbus 7
Hefei 7
Rio de Janeiro 7
Stockholm 7
Toronto 7
Collazzone 6
Des Moines 6
Dhaka 6
Glasgow 6
Incheon 6
San Francisco 6
Shanghai 6
Tashkent 6
Trinity 6
Baku 5
Belo Horizonte 5
Dong Ket 5
Jakarta 5
Lahore 5
Lappeenranta 5
Ottawa 5
Paris 5
Riyadh 5
Salvador 5
Turin 5
Vicenza 5
Woodbridge 5
Totale 3.492
Nome #
Histological muscle characterization in hypertrophied Marchigiana cattle breed 171
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 169
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 161
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 146
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 145
RAGE in the pathophysiology of skeletal muscle. 144
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 138
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 138
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 136
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 135
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 134
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 133
Equisetum arvense standardized extract hinders age-related sarcopenia 132
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 131
Natural products to counteract muscle atrophy 131
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 126
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 125
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 122
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 109
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 109
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 106
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 105
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 105
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 104
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 104
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 104
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 101
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 100
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 99
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 99
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 99
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 98
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 97
The effects of microgravity on human skeletal muscle regeneration. 97
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 96
The receptor RAGE: a potential molecular target in cancer cachexia 92
Reductive stress in striated muscle cells 92
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 91
S100 proteins in obesity: liaisons dangereuses 90
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 90
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 90
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 87
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 83
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 77
Self-powered temperature sensors harnessing membrane potential of living cells 73
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 73
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 71
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 71
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 68
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 67
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 65
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 57
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 55
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 51
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 11
Totale 5.703
Categoria #
all - tutte 22.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 11 7 7
2021/2022420 4 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/20262.083 140 116 96 276 308 206 384 155 229 173 0 0
Totale 5.703